Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Centennial Scholars Spotlight

Nov 1, 2022/Column

This month, APTA Magazine spotlights APTA Centennial Scholar Monique Pineros, PT, DPT.

States Acting To Expand Telehealth

Feb 1, 2021/Column

Here's a roundup of APTA national and chapter activities and resources to aid your state's efforts.

APTA Advocacy Win: Anthem Changes Payment Policy to Document Total Time per Code

Sep 24, 2025/News

After advocacy efforts from APTA staff and members, Anthem has changed its reimbursement policy so that PTs are no longer required to document start and stop times for each CPT code. 

MIPS Participation and Reporting Options

Feb 27, 2024/Resource

APTA provides details for the different MIPS participation and reporting options.

The Good Stuff: Members and the Profession in the Media, December 2022

Dec 14, 2022/Roundup

From radio personality to PT school, a tutorial in barbell squats, and more: APTA members in the media.

The Latest Patient Care Resources for APTA Members

Feb 13, 2025/Roundup

Resources to help guide your patient care are free to members and easy to find at apta.org. Here’s what was new in 2024.

Graded Symptom Checklist (GSC)

May 23, 2017/Test & Measure

Patients self rate the presence and severity of signs and symptoms such as blurred vision, dizziness, drowsiness, sleeping more than usual, easily distracted, fatigue, feeling “in a fog,” headache, and irritability.

Precision Care and Big Data Are Key to Keeping Up, Maley Lecturer Says

Nov 1, 2022/Feature

Sue Whitney repeatedly challenged the profession to "think bigger" — including around the importance of collecting data.

Just Watch: Tune In to APTA Videos for Vision, Insight, and Self-Care

Oct 29, 2021/Roundup

Tired of binging on Netflix? Watched all the TikTok dances you care to see? Invest in your personal and professional development instead.

More Physical Activity Linked to Better COVID-19 Outcomes

Jan 13, 2023/Review

Authors found a dose-response relationship between PA and adverse COVID-19 events that was consistent across multiple subgroups.